Drugs / OSTABOLIN-C
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00787358 Comparator | Dec 2008 → Jun 2009 | osteoporosis | Zelos Therapeutics | Withdrawn | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OSTABOLIN-C | ChEMBL registry synonym — accepted as the source's own label CHEMBL4802222 ↗ |
| Known as | PTH-1-31 CYCLIC | ChEMBL registry synonym — accepted as the source's own label CHEMBL4802222 ↗ |
| Known as | ZT-031 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00787358 ↗ |
| Action | Activate | “Parathyroid hormone receptor agonist” CHEMBL4802222 ↗ |
| Route | Subcutaneous | “80 ul subcutaneous injection per day” NCT00787358 ↗ |
| Target | PTH1R | “Parathyroid hormone receptor agonist” CHEMBL4802222 ↗ |